Search global stocks & ETFs...Ctrl K
Learn Mode
VTRS
Stock Profile
08-05
Recommended Metric
Score Card
Explore Scores Tab
2.64
Average
Valuation Score
Key Score
3.00
Average
Management
1.00
Very Bad
Growth
2.00
Bad
Profitability
4.00
Good
Fin. Health
1.00
Very Bad
Dividends
1.00
Very Bad
Analyst
2.00
Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$15.37
Baseline
High
$24.15
▲
57.12%
Avg
$17.48
▲
13.75%
Low
$12.12
▼
-21.15%
Analyst Ratings based on 18 Analysts
Strong Buy
422%
Buy
844%
Hold
528%
Sell
106%
Strong Sell
000%
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 30,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.Read More